Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
MedMira Stock Quote

MedMira (TSXV: MIR)

CA$0.09
(5.9%)
CA$0.00
Price as of April 12, 2024, 3:43 p.m. ET

MedMira Company Info

MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. Its tests provide hospitals, labs, clinics, and individuals with rapid diagnosis for diseases, including human immunodeficiency virus and hepatitis C. It offers its tests under the Reveala, Multiplo, and Miriad brands. The company was founded by Hermes Hermes Chan and Carlina Hui in 1993 and is headquartered in Halifax, Canada.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.